文献速递细菌感染、耐药与抗菌药物医院感染防控

利用既往培养结果改进初始经验性抗生素处方:一项简单临床启发式评估

Using Prior Culture Results to Improve Initial Empiric Antibiotic Prescribing: An Evaluation of a Simple Clinical Heuristic.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究在大型学术三级医院开展准实验研究,比较干预前后各9个月。干预包括评估经验性抗生素与近期MRSA监测拭子、既往ESBL培养及最近革兰阴性菌培养的临床显著不一致,并由抗菌药物管理药师提供建议。结果显示一致治疗比例从73%升至88%,一致治疗中位时间从55小时缩短至25小时,不必要万古霉素疗程中位减少1.1天。

要点

  • 干预提高经验性治疗与既往培养结果的一致性比例(73%→88%,P=.01)。
  • 干预缩短一致治疗中位时间(25 vs 55小时,P<.001)。
  • 干预减少不必要万古霉素疗程中位1.1天(95%CI .5-1.6,P<.001)。

核心结论

  • 该干预改善了处方行为,缩短了一致治疗时间,提高了一致治疗患者比例,并减少了不必要万古霉素使用。

研究设计与样本

  • 务实、前瞻性、全院干预,采用准实验设计比较干预前后两个9个月时期,地点为大型学术三级医院。

主要发现

  • 临床显著不一致在干预前识别99次,干预期识别86次。
  • 接受一致治疗的患者比例从对照组73%(72/99)升至干预组88%(76/86)(P=.01)。
  • 干预组一致治疗中位时间短于对照组(25 vs 55小时;P<.001;调整风险比=1.95[95%CI 1.37-2.77;P<.001])。
  • 不必要万古霉素治疗中位疗程减少1.1天(95%CI .5-1.6天;P<.001)。

关键数值与推荐

  • 评估经验性抗生素与最近MRSA监测拭子、既往ESBL培养及最近革兰阴性菌培养的临床显著不一致。
  • 若不一致,由抗菌药物管理药师提供替代治疗建议。

临床怎么用

  • 可将既往培养结果(MRSA监测拭子、ESBL培养、最近革兰阴性菌培养)纳入经验性抗生素选择评估。
  • 对临床显著不一致的处方,可由抗菌药物管理药师及时反馈并建议替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A patient's prior cultures can inform the subsequent risk of infection from resistant organisms, yet prescribers often fail to incorporate these results into their empiric antibiotic selection. Given that timely initiation of adequate antibiotics has been associated with improved outcomes, there is an urgent need to address this gap. METHODS: In order to better incorporate prior culture results in the selection of empiric antibiotics, we performed a pragmatic, prospective, hospital-wide intervention: (1) empiric antibiotic prescriptions were assessed for clinically significant discordance with the most recent methicillin-resistant Staphylococcus aureus (MRSA) surveillance swab, previous cultures for extended-spectrum beta-lactamases (ESBLs), and the most recent culture for a Gram-negative (GN) organism; and (2) if discordant, an antimicrobial stewardship pharmacist provided recommendations for alternative therapy. The impact was analyzed using a quasi-experimental design comparing two 9-month periods (pre- and postintervention) at a large academic, tertiary care institution. RESULTS: Clinically significant discordance was identified 99 times in the preintervention period and 86 times in the intervention period. The proportion of patients that received concordant therapy increased from 73% (72/99) in the control group to 88% (76/86) in the intervention group (P = .01). The median time to concordant therapy was shorter in the intervention group than the control group (25 vs 55 hrs, respectively; P < .001; adjusted hazard ratio = 1.95 [95% confidence interval {CI}, 1.37-2.77; P < .001]). The median duration of unnecessary vancomycin therapy was reduced by 1.1 days (95% CI, .5-1.6 days; P < .001). CONCLUSIONS: This intervention improved prescribing, with a shorter time to concordant therapy and an increased proportion of patients receiving empiric therapy concordant with prior culture results. The use of unnecessary vancomycin was also reduced.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Elligsen M, Pinto R, Leis JA, et al. Using Prior Culture Results to Improve Initial Empiric Antibiotic Prescribing: An Evaluation of a Simple Clinical Heuristic. Clin Infect Dis. 2021. PMID: 32930719. doi:10.1093/cid/ciaa1397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。